Rimas Orentas
cgtgaithersburg.bsky.social
Immunotherapy R&D - looking to develop immunotherapy, cell and gene therapy, and make an end to sickle cell disease.
👤 Joined on 12 November 2024
231
Followers
133
Following
55
Total Posts
📜 Kullanıcı Geçmişi
- 12 Kas 2024, 16:04
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@cgtgaithersburg.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
New: CIBMTR Research Outcomes after 7/8 and <7/8 mismatched unrelated donor PBSC transplantation with PTCy: Results from the ACCESS trial Read more: 🔗 pubmed.ncbi.nlm.nih.gov/42616616/
Show Post
No Kings theme at the weekly NIH Vigil. Voting is important!
Show Post
B7-H3 expression affects outcomes in myeloma and is targetable with an NK cell engager www.sciencedirect.com/science/arti...
Show PostThe kinase GSK3β drives the metabolism supporting the inflammatory function of pathogenic TH1 cells @mayoclinic.org science.org/doi/10.1126/...
Show Post📢 #Tandem27 registration is open! Join ASTCT and CIBMTR for the latest research, emerging therapies, and advances in transplantation and cellular therapy. 📍 Orlando, FL | 📅 Feb. 17-20, 2027 Register: www.tandemmeetings.com/Registration...
Show Post